You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Natalizumab an effective and safety therapy in patients with multiple sclerosis
- In: Hospital Pharmacy Posters
- At: Lisbon (Portugal) (2010)
- Type: Poster
- Poster code: HPS-P-021
- By: TORRES, Maria Alexandra (Hospitais da Universidade de Coimbra - Serviços Farmacêuticos, Coimbra, Portugal)
- Co-author(s): Campelo, Isabel (Hospitais da Universidade de Coimbra - Serviços Farmacêuticos, COIMBRA, Portugal)
Rodrigues, Ana Isabel (Hospitais da Universidade de Coimbra - Serviços Farmacêuticos, COIMBRA, Portugal)
Rocha, Marilia (Hospitais da Universidade de Coimbra - Serviços Farmacêuticos, COIMBRA, Portugal)
Cabral, Maria Adelaide (Hospitais da Universidade de Coimbra - Serviços Farmacêuticos, COIMBRA, Portugal) - Abstract:
Objective: The aim of the present study was to evaluate the effectiveness and safety of the new therapeutic agent, Natalizumab. Design: A three year (2007-2009) retrospective study of patients admitted to the three Neurology wards. Data were collected by physicians and the neurology pharmacist during the outpatient visit. Main Outcome Measures:..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026